FDA Inspection
Janssen Pharmaceutica NVJanssen Pharmaceutica NV – FDA Inspection, Oct 7, 2025
Record Details
This FDA Inspection record concerns Janssen Pharmaceutica NV, with an inspection on October 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Company
- Janssen Pharmaceutica NV
- Inspection Date
- October 7, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 582936a1-42bd-4881-8982-4d1e0ba9f860
Inspection Facts
- Inspection number
- 1302316
- FDA center
- Human Drugs
Other FDA inspections of Janssen Pharmaceutica NV
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Janssen Pharmaceutica NV
- FDA Inspection 1220158 - 2021-02-03
- FDA Inspection 878913 - 2014-05-16
- FDA Inspection 785854 - 2012-05-10
- FDA Inspection 591562 - 2009-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.